share_log

中国同辐(01763.HK)成立合资公司甘肃弘业

CIRC (01763.HK) has established a joint venture company, Gansu Hongye.

Gelonghui Finance ·  Dec 16 20:15

Gelonghui, December 16, 丨 China Tongpu (01763.HK) announced that on December 16, 2024, China Nuclear Qualcomm, a subsidiary of the company, signed an “Investment Agreement” with 404 Company and other investors to establish a joint venture company, Gansu Hongye. According to the “Investment Agreement”, Gansu Hongye's registered capital is RMB 95 million, of which the 404 company will invest RMB 57 million in currency, and the company's subsidiary CNNC Qualcomm will invest RMB 9.5 million in currency. After the establishment of Gansu Hongye, the 404 Company and its subsidiary CNNC Qualcomm will hold 60% and 10% of Gansu Hongye's shares respectively, and Gansu Hongye will become a subsidiary of the 404 Company.

Objective: To establish a technology company integrating back-end nuclide extraction and separation, radioactive source preparation, isotope product development, processing, sales, and waste source recycling to achieve resource utilization of radioactive waste, fill gaps in domestic isotope production, and form a complementary isotope technology product supply pattern with domestic peers.

Gansu Hongye is a specialized company established by the 404 Company in conjunction with a local government investment platform to extract radioactive isotope products using high-emission waste liquid treatment liquid generated during the spent fuel post-treatment process as raw materials. After production is put into operation, it will be the only supplier of spent fuel post-treatment isotopes in China. The “Investment Agreement” was established to establish Gansu Hongye, which is conducive to industrialized application of spent fuel isotope extraction technology and utilization of high-emission waste liquid resources, and reduces the risk of sources of isotope-related raw materials in China.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment